FDA Staff: Gilead Sciences, Inc.'s Truvada May Help Prevent HIV Infection

Published: May 08, 2012

Gilead Sciences Inc's Truvada may prevent HIV infection among high-risk individuals, if used in combination with other health strategies, and is well-tolerated by individuals who have not contracted the virus that causes AIDS, U.S. Food and Drug Administration review documents said on Tuesday.

Back to news